跳至主要内容
临床试验/NCT01562184
NCT01562184已完成2 期

A Controlled Trial of Transcranial Direct Current Stimulation as a Treatment for Unipolar and Bipolar Depression

The University of New South Wales12 个研究点 分布在 2 个国家目标入组 120 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
120
试验地点
12
主要终点
Montgomery Asberg Depression Rating Scale for Depression (MADRS)

研究概览

简要总结

Transcranial direct current stimulation (tDCS) is a novel treatment approach for depression that has shown promising efficacy in four recent double-blind, randomized, sham-controlled trials (RCT) and a meta-analysis. This study is a RCT of tDCS in depressed patients, testing its efficacy in both unipolar and bipolar depression. Mood, cognitive test performance and biomarkers will be measured during the trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or above.
  • Meets criteria for a DSM-IV Major Depressive Episode with duration of at least 4 weeks.
  • Total score ≥ 20 on the Montgomery-Asberg Depression Rating Scale at study entry.

排除标准

  • Current episode duration greater than 3 years.
  • Failed more than 3 adequate antidepressant trials in current episode.
  • DSM-IV psychotic disorder.
  • Drug or alcohol abuse or dependence (preceding 3 months).
  • Inadequate response to ECT in the current episode of depression.
  • Rapid clinical response required, e.g., high suicide risk.
  • Significant acute suicide risk, defined as follows: suicide attempt within the previous 6 months that required medical treatment; or ≥ 2 suicide attempts in the past 12 months; or has a clear-cut plan for suicide and states that they cannot guarantee that they will call their regular psychiatrist or the investigator if the impulse to implement the plan becomes substantial during the study; or in the investigator's opinion, is likely to attempt suicide within the next 6 months.
  • Clinically defined neurological disorder or insult.
  • Metal in the cranium, skull defects, or skin lesions on scalp (cuts, abrasions, rash) at proposed electrode sites.
  • Pregnancy.
  • Concurrent long acting benzodiazepines, ritalin or dexamphetamine medication.

结局指标

主要结局

Montgomery Asberg Depression Rating Scale for Depression (MADRS)

时间窗: 12 weeks

次要结局

  • Quick Inventory of Depressive Symptomatology - Self Report (QIDS-SR)(12 weeks)
  • Montreal Cognitive Assessment (MoCA): Global Cognitive Function(8 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Colleen Loo

Professor

The University of New South Wales

研究点 (12)

Loading locations...

相似试验